Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 24, 2006 Alyce Lomax	The Genetically Modified Conundrum What's in your food? Some companies don't want you to know. GM foods are bolstering the profits of companies like Monsanto, and there are some logical reasons why anti-GM advocates suspect a level of foul play.
Pharmaceutical Executive October 1, 2011 Ansis Helmanis	Lessons from the FDA Front Line Is the research-based industry less productive today than 30 years ago? To former Commissioner Jane Henney, the answer is straightforward.
Chemistry World January 21, 2010 Rebecca Renner	FDA shifts on BPA safety The US Food and Drug Administration has revised its position on the possible developmental health risks from bisphenol A, the controversial and widely used ingredient in hard plastic bottles and food packaging that it declared safe in 2008.
The Motley Fool March 24, 2009 Brian Orelli	Taking the F Out of FDA President Barack Obama's nomination for deputy commissioner of the Food and Drug Administration has gotten people talking about the possibility of splitting the food safety portion away from the drug portion of the agency.
The Motley Fool March 23, 2007 Alyce Lomax	Is Monsanto Going to Seed? Several recent news headlines referring to its genetically modified products should give investors some reason to contemplate the risks that face this biotech giant.
Pharmaceutical Executive February 1, 2011 Jill Wechsler	Challenges, Changes, Commitments The Three Cs could be taxing on FDA resources as the new Congress brings stiffer oversight and leadership revisions to the agency
The Motley Fool October 18, 2006 Brian Lawler	Another Hard Pill to Swallow A former FDA chief will take the fall for not disclosing holdings, but the pharmaceuticals industry needs more than that.
Food Processing January 2005 David Joy	Regulatory Issues: The FDA agenda for 2005 As in the past, the FDA has a full agenda of food regulatory matters in 2005. So it's not good that the FDA's scientists are demoralized and the agency stands accused of being too friendly with a regulated industry.
Chemistry World May 21, 2009 Rebecca Trager	FDA gets new chief The US Food and Drug Administration's (FDA) new commissioner, Margaret Hamburg, will be the second woman to ever lead FDA
Food Engineering April 3, 2009	Extreme HHS makeover Keeping America's Food Safe: A Blueprint for Fixing the Food Safety System at the US Department of Health and Human Services, examines problems with the department
Pharmaceutical Executive January 1, 2009 Jill Wechsler	FDA Turnaround Time Will more resources and new leadership fix FDA, or is a major overhaul in order?
Chemistry World January 11, 2016 Rebecca Trager	Monsanto adds 1000 to job cut tally The company had already revealed plans to cut 2,600 jobs over the next two years, and the new plan brings the total up to 16% of the company's global workforce.
The Motley Fool May 27, 2009 Brian Orelli	Meet the People Who'll Rule Your Investment Life If you're a drug company investor, that is. The new commissioner and principal deputy commissioner of the Food and Drug Administration introduced themselves and give investors a first look at how they plan to run the agency.
Chemistry World March 1, 2010 Rebecca Trager	US launches new regulatory science program Two major US government agencies have partnered to create a new regulatory science program to ensure better integration between cutting edge science and regulatory processes in assessing new medical products or compounds flowing from biomedical research.
Food Processing October 2008 Diane Toops	A Conversation with Food Safety Czar David W.K. Acheson A exclusive conversation with `food safety czar' David W.K. Acheson, FDA's Associate Commissioner for Foods.
Pharmaceutical Executive December 1, 2011 Jill Wechsler	FDA Gets a New Look Agency expansion and globalization promote innovation, collaboration, and organizational changes
Food Engineering March 2, 2009	FDA Still Under Fire for Peanut Butter Crisis A key member of the US Senate is losing patience with the FDA over food safety issues.
The Motley Fool December 5, 2006 Brian Gorman	Monsanto Needs to Charm The company has to confront concerns over genetically modified foods soon if it hopes to keep growing. Investors, take note.
Food Engineering January 1, 2009	Regulatory Watch: Improved FDA plan for food protection Under increasing criticism for its oversight of the nation's food supply, FDA issued a plan to better protect food from accidental and intentional contamination.
Chemistry World July 19, 2012 Rebecca Trager	US bans BPA in baby bottles The US Food and Drug Administration's ban on the use of bisphenol A in baby bottles and children's sippy cups is being celebrated by industry and environmental groups, but many stakeholders are calling it too little too late.
Nutrition Action Healthletter June 2000 Michael F. Jacobson	News From CSPI Critics and advocates of crops that are engineered to carry genes from other species are waging a battle royal. The public will hotly debate biotechnology for years to come. Our goal should be to throw out any dirty bathwater, but not the baby.
Chemistry World November 4, 2008 Rebecca Trager	FDA criticised by its own experts over bisphenol A The US Food and Drug Administration (FDA)'s recent conclusion that controversial chemical bisphenol A (BPA) is safe at current levels is flawed, the agency's own Science Board has warned.
The Motley Fool August 20, 2008 Brian Orelli	A Moooving Acquisition Eli Lilly buys Monsanto's cow hormone business.
AskMen.com Sebastien Stefanov	Are Modified Foods Dangerous? What foods are potentially dangerous, what are the risks and how can consumers protect themselves against this new industry?
Science News November 1, 2003 Janet Raloff	Hormones in Your Milk Four dairies got their proverbial hands slapped by the U.S. FDA for marketing what it charges is "misbranded" milk, with labels containing false statements about the food's hormone status.
Pharmaceutical Executive January 1, 2007	Thoughtleader: Peter Pitts. DrugWonks.com Here, the chief voice of a blog hosted by the non-profit Center for Medicine in the Public Interest urges pharma to continuously plug its positions and get politics out of science, and offers some perspective on important regulatory reforms facing the FDA.
The Motley Fool March 23, 2006 Alyce Lomax	Monsanto: Monster Stock, or Just Plain Monster? Many things seem to be going right for Monsanto. However, what price are you willing to pay for growth? Are the profits worth the risks -- and the possible long-term ramifications -- for both investors and consumers?
Pharmaceutical Executive September 1, 2005 Jill Wechsler	Washington Report: Crawford Steps Up As FDA's new commissioner takes the reins, his key challenge is restoring trust in the agency.
Food Processing February 2006 Dave Fusaro	Editor's Plate: Is biotechnology the future of food? Why not a conference on biotechnology, but with the food industry calling the meeting to order?
Bio-IT World August 13, 2003 Brian Reid	Remaking the FDA New commissioner is pushing for greater use of technology and innovation to speed the flow of drugs to market.
Pharmaceutical Executive January 1, 2006 Kenneth I. Kaitin	Opinion: Memo to von Eschenbach FDA's acting commissioner has an opportunity to clarify a lot of misconceptions about the agency's role in regulating drug safety. His first order of business should be to explain exactly what FDA doesn't do.
Food Processing May 2006 David Joy	Regulatory Issues: FDA may cut food-contact program The agency's proposed budget may mean an end to the efficient and speedy Food Contact Notification Program -- and two- to five-year waits for reviews.
Chemistry World October 12, 2015 Rebecca Trager	Monsanto plans 2600 layoffs The cuts, which will slash the company's workforce by about 12%, are part of a cost-saving plan to address declining sales of its biotech seeds and herbicides.
Chemistry World April 4, 2012 Rebecca Trager	FDA backs use of BPA in food packaging The US Food and Drug Administration says there is insufficient scientific evidence to ban bisphenol A in food packaging.
Food Engineering December 1, 2008	Regulatory Watch: Will food safety be a priority for Obama? A strong FDA Commissioner is seen as a first step toward restoring integrity to the food inspection process.
Food Processing October 2012	FDA Assesses its FSMA Progress The Deputy Commissioner for Foods, Michael Taylor, outlines his accomplishments and his to-do list.
Food Processing February 2006 Leslie T. Krasny	Regulatory Issues: FDA Denies Petition on Whole Grain Descriptors Currently, hundreds of products are marketed with "whole grain" statements, despite ambiguity concerning the regulatory status of descriptors such as "good" and "excellent" source.
Food Processing July 2005 David Joy	Regulatory Issues: What's in a name? The Food and Drug Administration and the U.S. Dept. of Agriculture recently published a joint proposal to amend their regulations dealing with food "standards of identity."
The Motley Fool April 9, 2007 Ryan Fuhrmann	Scrutinizing Monsanto's Outlook Food for thought about what's driving Monsanto. Investors, in many respects, considering Monsanto is more akin to finding opportunities in biotechnology than looking into the heartland.
Bio-IT World September 11, 2003 John Russell	This Goose Is Better Uncooked From 'Poison Squad' to pharma watchdog, the ever-changing and controversial role of the FDA makes for fascinating history.
Pharmaceutical Executive April 1, 2007 Patrick Clinton	From the Editor: Taking It Outside FDA Commissioner Andy von Eschenbach said something pretty reasonable, and in return received a blistering, menacing letter from Senator Charles Grassley -- a letter that showed yet again that Grassley just doesn't understand what he's destroying in his campaign against FDA.
The Motley Fool January 14, 2008 Brian Lawler	Score One for Dendreon and Disclosure A prestigious journal supports Dendreon's potential prostate cancer treatment, and makes a compelling case for more FDA disclosure.
Food Processing October 2006 Leslie Krasny	Regulatory Roundup As the legislative year grinds to a halt, here's what's left undone -- and what will be sitting on the table when things pick up again.
The Motley Fool August 18, 2008 Zoe Van Schyndel	Funds for a Sick Economy? The biotech sector has been a sleeper with positive returns. Take a look at two biotech mutual funds that are performance leaders.
Finance & Development March 2008 Prakash Loungani	People in Economics An interview with Stanford University's John Taylor, one of the most honored macroeconomists of our time.
The Motley Fool December 31, 2007 Brian Lawler	Does Leadership Count at the FDA? Let's take a look at how drug approval rates have fared under different FDA commissioners.
The Motley Fool March 31, 2008 Brian Lawler	FDA Commish Joins Blogosphere Andrew von Eschenbach, the FDA's chief, starts a weekly blog.
Food Engineering January 6, 2008	Regulatory Watch Push for larger FDA food safety budget... Study urged on food from cloned animal...
Pharmaceutical Executive April 1, 2009 Patrick Clinton	Dear Commissioner... Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.
The Motley Fool April 8, 2004 Charly Travers	Indevus' Big Score (Maybe) A small biotech company lands a potentially rich deal.